Posted on May 6: McMaster University vector laboratory a first for Canada

For scientists, creating new vaccines to treat diseases such as cancer is only part of the puzzle. Equally important are the vectors or delivery agents that will be used to transport the vaccines into a patient's body. This is a complex process and, until now, there has been no university facility in Canada able to develop vectors suitable for use in people. Scientists have had to go to the United States and wait in line for laboratory space. Thanks to a $1-million gift from McMaster alumni Robert Fitzhenry to support gene therapeutic research, McMaster University is firmly on the path to a new era in medical discovery. His gift will establish the Robert E. Fitzhenry Vector Laboratory as the first Good Manufacturing Practice (GMP) laboratory in Canada capable of producing vectors for use in clinical trials for patients. GMP is a set of regulations that ensure the identity, potency, safety and purity of pharmaceutical products. "I was overwhelmed when I learned what a huge stride forward the establishment of this vector laboratory would represent, not only for McMaster but for medical researchers across Canada who would now have access to Canadian produced vectors," said Fitzhenry, the former vice chair & COO of Woodbridge Foam Corporation in Mississauga, and a graduate of McMaster University in political economy.

Read More